CIK 0001360214
- Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450567010
- Phone
- +1 615-733-4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Open-market buy 10% owner bought 72,500 shares at an average $8.62 ($624,697)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 20,000 shares at an average $7.31 ($146,290)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 74,584 shares at an average $8.34 ($622,389)
- 4 Open-market sale Director sold 10,000 shares at $10.75 ($107,500)
- 4 Shares withheld for taxes Chief Financial Officer gave up 49,832 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 334,129 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 1,518,000 shares at $7.00 ($10,626,000)
- 4 Exercise or conversion Chief Executive Officer acquired 200,000 shares (option exercise)
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,500 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 106,416 shares at an average $5.26 ($559,482)
Page 6 of 15 · 296 filings